melatonin has been researched along with Syndrome in 48 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 9.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "The occurrence of headache and its change after treatment with melatonin 5 mg were studied in 30 patients with delayed sleep phase syndrome." | 9.08 | Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. ( Kerkhof, GA; Nagtegaal, JE; Smits, MG; Swart, AC; van der Meer, YG, 1998) |
| "The aim of our study is to search diagnostic tools for early detection of prenosological melatonin deficiency in postmenopausal women and women in menopausal transition with climacteric syndrome for establishment effective personalized prevention and treatment programs." | 7.91 | [Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.] ( Mamontova, AG; Soloviev, AG; Usoltseva, EN, 2019) |
| " Study groups were formed as follows: (1) control group, (2) ischemia group, (3) selenium + ischemia group, (4) melatonin + ischemia group, and (5) selenium + melatonin + ischemia group." | 7.91 | Effects of Selenium and Melatonin on Ocular Ischemic Syndrome. ( Telek, HH, 2019) |
| "An inverted circadian rhythm of melatonin (MT) likely contributes to the sleep disturbance in patients with Smith-Magenis syndrome (SMS)." | 7.76 | Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome. ( Chik, CL; Duncan, WC; Rollag, MD; Smith, AC, 2010) |
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 7.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| "The objective was to determine the circadian rhythm of melatonin in the Smith-Magenis syndrome (SMS), which causes behavioral problems and sleep disturbance." | 7.71 | Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. ( Albrecht, U; Claustrat, B; De Blois, MC; De Leersnyder, H; Delobel, B; Lyonnet, S; Munnich, A; Romana, S; Vekemans, M; Viot, G; Von Kleist-Retzow, JC, 2001) |
| "To assess urine levels of melatonin measured by 6-sulphatoxymelatonin (aMT6s) in patients with fibromyalgia (FM)." | 7.70 | Normal melatonin levels in patients with fibromyalgia syndrome. ( Abu-Shakra, M; Barak, R; Buskila, D; Neumann, L; Phillip, M; Press, J; Segev, Y, 1998) |
| "Our data indicate a disturbed circadian rhythm in melatonin and document the disturbed sleep pattern in Smith-Magenis syndrome." | 7.70 | Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. ( Glaze, D; Kashork, CD; Lupski, JR; Park, SS; Potocki, L; Reiter, RJ; Shaffer, LG; Tan, DX, 2000) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 7.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "Melatonin 5 mg was administered during two weeks in a double-blind setting and two weeks in an open setting successively or interrupted by two week of placebo." | 6.69 | Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. ( Kerkhof, GA; Nagtegaal, JE; Smits, MG; Swart, AC; Van Der Meer, YG, 1998) |
| "Smith-Magenis syndrome (SMS) is a mental retardation syndrome with distinctive behavioral characteristics, dysmorphic features and congenital anomalies ascribed to an interstitial deletion of chromosome 17p11." | 6.43 | Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. ( De Leersnyder, H, 2006) |
| "Mental retardation is constant; there are major behavioral disturbances and severe sleep disorders." | 5.32 | [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome]. ( Bresson, JL; Claustrat, B; de Blois, MC; De Leersnyder, H; Munnich, A; Sidi, D, 2003) |
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 5.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "The occurrence of headache and its change after treatment with melatonin 5 mg were studied in 30 patients with delayed sleep phase syndrome." | 5.08 | Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. ( Kerkhof, GA; Nagtegaal, JE; Smits, MG; Swart, AC; van der Meer, YG, 1998) |
| "The aim of our study is to search diagnostic tools for early detection of prenosological melatonin deficiency in postmenopausal women and women in menopausal transition with climacteric syndrome for establishment effective personalized prevention and treatment programs." | 3.91 | [Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.] ( Mamontova, AG; Soloviev, AG; Usoltseva, EN, 2019) |
| " Study groups were formed as follows: (1) control group, (2) ischemia group, (3) selenium + ischemia group, (4) melatonin + ischemia group, and (5) selenium + melatonin + ischemia group." | 3.91 | Effects of Selenium and Melatonin on Ocular Ischemic Syndrome. ( Telek, HH, 2019) |
| "An inverted circadian rhythm of melatonin (MT) likely contributes to the sleep disturbance in patients with Smith-Magenis syndrome (SMS)." | 3.76 | Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome. ( Chik, CL; Duncan, WC; Rollag, MD; Smith, AC, 2010) |
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 3.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| "The objective was to determine the circadian rhythm of melatonin in the Smith-Magenis syndrome (SMS), which causes behavioral problems and sleep disturbance." | 3.71 | Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. ( Albrecht, U; Claustrat, B; De Blois, MC; De Leersnyder, H; Delobel, B; Lyonnet, S; Munnich, A; Romana, S; Vekemans, M; Viot, G; Von Kleist-Retzow, JC, 2001) |
| "To assess urine levels of melatonin measured by 6-sulphatoxymelatonin (aMT6s) in patients with fibromyalgia (FM)." | 3.70 | Normal melatonin levels in patients with fibromyalgia syndrome. ( Abu-Shakra, M; Barak, R; Buskila, D; Neumann, L; Phillip, M; Press, J; Segev, Y, 1998) |
| "Diurnal rhythm of serum melatonin concentrations was estimated in 12 men with low back pain syndrome before and after exposure to a very low-frequency magnetic field (2." | 3.70 | Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentrations in humans. ( Czernicki, J; Karasek, M; Swietoslawski, J; Woldanska-Okonska, M; Zylinska, K, 1998) |
| "Our data indicate a disturbed circadian rhythm in melatonin and document the disturbed sleep pattern in Smith-Magenis syndrome." | 3.70 | Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. ( Glaze, D; Kashork, CD; Lupski, JR; Park, SS; Potocki, L; Reiter, RJ; Shaffer, LG; Tan, DX, 2000) |
| "The daily rhythms of melatonin, cortisol and body temperature were studied in 16 institutionalized subjects with the Lennox-Gastaut syndrome." | 3.68 | Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders. ( Alila, A; Hätönen, T; Heiskala, H; Laakso, ML; Leinonen, L, 1993) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 3.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "One hundred patients with sleep disorders and asthenic syndrome of various etiology and severity were studied." | 2.90 | [Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome]. ( Esipov, AV; Ivolgin, AF; Kalyagin, IE; Karakozov, AG; Katenko, SV; Kazakov, SP; Khritinin, DF; Levchenko, OB; Molodova, AI, 2019) |
| "Melatonin 5 mg was administered during two weeks in a double-blind setting and two weeks in an open setting successively or interrupted by two week of placebo." | 2.69 | Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. ( Kerkhof, GA; Nagtegaal, JE; Smits, MG; Swart, AC; Van Der Meer, YG, 1998) |
| " More extensive studies will be required to clarify the factors of dose-response and phase-response." | 2.69 | Light mask 500 lux treatment for delayed sleep phase syndrome. ( Ando, K; Cole, RJ; Elliott, JA; Kripke, DF, 1999) |
| "Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology." | 2.52 | Selective serotonin reuptake inhibitors for fibromyalgia syndrome. ( Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B, 2015) |
| "Smith-Magenis syndrome (SMS) is a mental retardation syndrome with distinctive behavioral characteristics, dysmorphic features and congenital anomalies ascribed to an interstitial deletion of chromosome 17p11." | 2.43 | Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. ( De Leersnyder, H, 2006) |
| "Circadian rhythm sleep disorders which may result from dysfunction of biological clock have recently been noticed and the number of patients suffering from these types of sleep disorders have been increased." | 2.40 | [Advanced sleep phase syndrome (ASPS) and delayed sleep phase syndrome (DSPS)]. ( Kajimura, N; Takahashi, K, 1998) |
| "Mental retardation is constant; there are major behavioral disturbances and severe sleep disorders." | 1.32 | [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome]. ( Bresson, JL; Claustrat, B; de Blois, MC; De Leersnyder, H; Munnich, A; Sidi, D, 2003) |
| "A hypnic headache was captured in one patient arising out of rapid eye movement sleep at a time of severe oxygen desaturation." | 1.31 | Polysomnography in hypnic headache syndrome. ( Dodick, DW, 2000) |
| "Treatment with cyproheptadine produced improvement of symptoms in 76% of cases." | 1.30 | Characterisation of headshaking syndrome--31 cases. ( Bell, SA; Madigan, JE, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.42) | 18.7374 |
| 1990's | 17 (35.42) | 18.2507 |
| 2000's | 17 (35.42) | 29.6817 |
| 2010's | 8 (16.67) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Korshnyak, VО | 1 |
| Pulyk, ОR | 1 |
| Stoyanov, ОM | 1 |
| Esipov, AV | 1 |
| Ivolgin, AF | 1 |
| Khritinin, DF | 1 |
| Katenko, SV | 1 |
| Kazakov, SP | 1 |
| Karakozov, AG | 1 |
| Kalyagin, IE | 1 |
| Levchenko, OB | 1 |
| Molodova, AI | 1 |
| Usoltseva, EN | 1 |
| Soloviev, AG | 1 |
| Mamontova, AG | 1 |
| Telek, HH | 1 |
| Chojnacki, C | 1 |
| Poplawski, T | 1 |
| Blasiak, J | 1 |
| Chojnacki, J | 1 |
| Klupinska, G | 1 |
| Lammers, M | 1 |
| Ahmed, AIA | 1 |
| Walitt, B | 1 |
| Urrútia, G | 1 |
| Nishishinya, MB | 1 |
| Cantrell, SE | 1 |
| Häuser, W | 1 |
| Benarroch, EE | 1 |
| Boudreau, EA | 1 |
| Johnson, KP | 1 |
| Jackman, AR | 1 |
| Blancato, J | 1 |
| Huizing, M | 1 |
| Bendavid, C | 1 |
| Jones, M | 1 |
| Chandrasekharappa, SC | 1 |
| Lewy, AJ | 1 |
| Smith, AC | 2 |
| Magenis, RE | 1 |
| Chik, CL | 1 |
| Rollag, MD | 1 |
| Duncan, WC | 1 |
| Mahdi, AA | 1 |
| Fatima, G | 1 |
| Das, SK | 1 |
| Verma, NS | 1 |
| De Leersnyder, H | 6 |
| Bresson, JL | 2 |
| de Blois, MC | 4 |
| Souberbielle, JC | 1 |
| Mogenet, A | 1 |
| Delhotal-Landes, B | 1 |
| Salefranque, F | 1 |
| Munnich, A | 5 |
| Boivin, DB | 1 |
| James, FO | 1 |
| Santo, JB | 1 |
| Caliyurt, O | 1 |
| Chalk, C | 1 |
| Cornélissen, G | 1 |
| Halberg, F | 1 |
| Tarquini, R | 1 |
| Perfetto, F | 1 |
| Salti, R | 1 |
| Laffi, G | 1 |
| Otsuka, K | 1 |
| Sidi, D | 2 |
| Claustrat, B | 3 |
| Frank, LA | 1 |
| Hnilica, KA | 1 |
| Oliver, JW | 1 |
| Wheeler, B | 1 |
| Taylor, B | 1 |
| Simonsen, K | 1 |
| Reith, DM | 1 |
| Verloes, A | 1 |
| Carpizo, R | 1 |
| Martínez, A | 1 |
| Mediavilla, D | 1 |
| González, M | 1 |
| Abad, A | 1 |
| Sánchez-Barceló, EJ | 1 |
| Bersani, G | 1 |
| Russo, D | 1 |
| Limpido, L | 1 |
| Marconi, D | 1 |
| Laakso, ML | 1 |
| Leinonen, L | 1 |
| Hätönen, T | 1 |
| Alila, A | 1 |
| Heiskala, H | 1 |
| Rúzsás, C | 1 |
| Ghosh, M | 1 |
| Rékási, Z | 1 |
| Mess, M | 1 |
| Sasaki, M | 1 |
| Kajimura, N | 1 |
| Takahashi, K | 1 |
| Kohsaka, M | 1 |
| Press, J | 1 |
| Phillip, M | 1 |
| Neumann, L | 1 |
| Barak, R | 1 |
| Segev, Y | 1 |
| Abu-Shakra, M | 1 |
| Buskila, D | 1 |
| Dagan, Y | 1 |
| Yovel, I | 1 |
| Hallis, D | 1 |
| Eisenstein, M | 1 |
| Raichik, I | 1 |
| Nagtegaal, JE | 2 |
| Smits, MG | 2 |
| Swart, AC | 2 |
| Kerkhof, GA | 2 |
| van der Meer, YG | 2 |
| Hashimoto, S | 1 |
| Nakamura, K | 1 |
| Honma, S | 1 |
| Honma, K | 1 |
| Karasek, M | 1 |
| Woldanska-Okonska, M | 1 |
| Czernicki, J | 1 |
| Zylinska, K | 1 |
| Swietoslawski, J | 1 |
| Pirritano, M | 1 |
| Lucidi, F | 1 |
| Violani, C | 1 |
| Ando, K | 1 |
| Kripke, DF | 1 |
| Cole, RJ | 1 |
| Elliott, JA | 1 |
| Uchiyama, M | 1 |
| Okawa, M | 1 |
| Shibui, K | 1 |
| Kim, K | 1 |
| Kudo, Y | 1 |
| Hayakawa, T | 1 |
| Kamei, Y | 1 |
| Urata, J | 1 |
| Madigan, JE | 1 |
| Bell, SA | 1 |
| Birketvedt, GS | 1 |
| Florholmen, J | 1 |
| Sundsfjord, J | 1 |
| Osterud, B | 1 |
| Dinges, D | 1 |
| Bilker, W | 1 |
| Stunkard, A | 1 |
| Potocki, L | 1 |
| Glaze, D | 1 |
| Tan, DX | 1 |
| Park, SS | 1 |
| Kashork, CD | 1 |
| Shaffer, LG | 1 |
| Reiter, RJ | 1 |
| Lupski, JR | 1 |
| Dodick, DW | 1 |
| Romana, S | 1 |
| Albrecht, U | 1 |
| Von Kleist-Retzow, JC | 1 |
| Delobel, B | 1 |
| Viot, G | 1 |
| Lyonnet, S | 1 |
| Vekemans, M | 2 |
| Villain, E | 1 |
| Kindermans, C | 1 |
| Alvarez, B | 1 |
| Dahlitz, MJ | 1 |
| Vignau, J | 1 |
| Parkes, JD | 1 |
| von Knorring, L | 1 |
| Almay, BG | 1 |
| Häggendal, J | 1 |
| Johansson, F | 1 |
| Oreland, L | 1 |
| Wetterberg, L | 2 |
| Kasper, S | 1 |
| Wehr, TA | 1 |
| Rosenthal, NE | 1 |
| Rittey, CD | 1 |
| Evans, TJ | 1 |
| Gray, CE | 1 |
| Paton, RD | 1 |
| Bojkowski, C | 1 |
| Thompson, C | 1 |
| Obrecht, R | 1 |
| Franey, C | 1 |
| Arendt, J | 1 |
| Checkley, SA | 1 |
| Beck-Friis, J | 1 |
| Kjellman, BF | 1 |
| Aperia, B | 1 |
| Undén, F | 1 |
| von Rosen, D | 1 |
| Ljunggren, JG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Determine the Effects of Selenium and Melatonin on Ocular Ischemic Syndrome[NCT04005222] | Early Phase 1 | 28 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| Melatonin Levels in Sleep-disordered Smith-Magenis Syndrome: a Pilot Study[NCT00691574] | 5 participants (Actual) | Interventional | 1998-09-30 | Terminated (stopped due to Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.) | |||
| Does CBT Improve the Effect of Light Therapy in Delayed Sleep Phase Syndrome Compared to Only Light Therapy - Short and Long Term Follow up[NCT01419938] | 57 participants (Actual) | Interventional | 2011-08-31 | Completed | |||
| Characterization of Endogenous Melatonin Profiles in Children With Autism Spectrum Disorder.[NCT00691080] | 58 participants (Actual) | Observational | 2007-09-30 | Completed | |||
| A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)[NCT00506259] | Phase 1 | 23 participants (Actual) | Interventional | 2007-07-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for melatonin and Syndrome
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxe | 2015 |
Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations.
Topics: Aging; Alzheimer Disease; Animals; Circadian Rhythm; Humans; Melatonin; Pineal Gland; Sleep Wake Dis | 2008 |
Abnormality of circadian rhythm of serum melatonin and other biochemical parameters in fibromyalgia syndrome.
Topics: Circadian Rhythm; Fibromyalgia; Humans; Melatonin; Syndrome | 2011 |
Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment.
Topics: Abnormalities, Multiple; Circadian Rhythm; Humans; Intellectual Disability; Melatonin; Sleep Wake Di | 2006 |
[Jet lag syndrome].
Topics: Circadian Rhythm; Humans; Hypnotics and Sedatives; Melatonin; Phototherapy; Sleep Wake Disorders; Sy | 1998 |
[Advanced sleep phase syndrome (ASPS) and delayed sleep phase syndrome (DSPS)].
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Chronotherapy; Circadian Rhythm; Humans; Melatonin; P | 1998 |
[Non-24-hour sleep-wake syndrome].
Topics: Chronotherapy; Circadian Rhythm; Humans; Melatonin; Phototherapy; Sleep Wake Disorders; Syndrome; Ti | 1998 |
[Season-related forms of depression. II. Modification by phototherapy and biological results].
Topics: Depressive Disorder; Humans; Melatonin; Neurotransmitter Agents; Phototherapy; Seasons; Syndrome | 1988 |
9 trials available for melatonin and Syndrome
| Article | Year |
|---|---|
[Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome].
Topics: Administration, Oral; Antioxidants; Asthenia; Drug Combinations; Flavin Mononucleotide; Humans; Inos | 2019 |
Does melatonin homeostasis play a role in continuous epigastric pain syndrome?
Topics: Abdominal Pain; Acetylserotonin O-Methyltransferase; Adult; Arylalkylamine N-Acetyltransferase; Case | 2013 |
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Acebutolol; Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic | 2003 |
Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alopecia; Androstenedion | 2004 |
Melatonin treatment in Smith Magenis syndrome.
Topics: Antioxidants; Chronobiology Disorders; Double-Blind Method; Humans; Intellectual Disability; Melaton | 2005 |
Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS).
Topics: Adult; Circadian Rhythm; Female; Humans; Male; Melatonin; Patient Selection; Sleep; Sleep Wake Disor | 1998 |
Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations.
Topics: Adolescent; Biological Clocks; Double-Blind Method; Female; Headache; Humans; Male; Melatonin; Middl | 1998 |
Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset.
Topics: Adult; Antioxidants; Body Temperature; Cross-Over Studies; Double-Blind Method; Female; Humans; Ligh | 1998 |
Light mask 500 lux treatment for delayed sleep phase syndrome.
Topics: Adult; Affect; Analysis of Variance; Biomarkers; Body Temperature; Circadian Rhythm; Female; Humans; | 1999 |
31 other studies available for melatonin and Syndrome
| Article | Year |
|---|---|
REHABILITATION OF PATIENTS WITH LONG-TERM AFTEREFFECTS OF MILD COMBAT TRAUMATIC BRAIN INJURY.
Topics: Asthenia; Brain Concussion; Humans; Melatonin; Syndrome | 2022 |
[Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.]
Topics: Adult; Climacteric; Female; Humans; Melatonin; Menopause; Middle Aged; Perimenopause; Precision Medi | 2019 |
Effects of Selenium and Melatonin on Ocular Ischemic Syndrome.
Topics: Aged; Aged, 80 and over; Eye; Female; Glutathione; Humans; Ischemia; Male; Malondialdehyde; Melatoni | 2019 |
Melatonin for sundown syndrome and delirium in dementia: is it effective?
Topics: Aged, 80 and over; Alzheimer Disease; Central Nervous System Depressants; Delirium; Dose-Response Re | 2013 |
Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion.
Topics: Abnormalities, Multiple; Chromosome Deletion; Chromosomes, Human, Pair 17; Female; Humans; Intellect | 2009 |
Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Antipsychotic Agents; Case-Control Studies; Child; Child | 2010 |
Non-24-hour sleep-wake syndrome following a car accident.
Topics: Accidents, Traffic; Adult; Circadian Rhythm; Craniocerebral Trauma; Female; Humans; Melatonin; Sleep | 2003 |
Point and interval estimations of circadian melatonin ecphasia in Smith-Magenis syndrome.
Topics: Adolescent; Adult; Child; Chromosome Deletion; Chromosomes, Human, Pair 17; Congenital Abnormalities | 2003 |
[Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].
Topics: Abnormalities, Multiple; Adolescent; Adrenergic beta-Antagonists; Child; Child, Preschool; Chromosom | 2003 |
Overdoing the late-night nosh. Some people get into an unhealthy pattern of nighttime eating. Depression or hormonal imbalances may be to blame.
Topics: Depression; Feeding and Eating Disorders; Feeding Behavior; Humans; Melatonin; Syndrome; Time Factor | 2005 |
Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome.
Topics: Child; Circadian Rhythm; Developmental Disabilities; Genetic Diseases, Inborn; Humans; Melatonin; Ne | 2006 |
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antioxidants; Child, Preschool; Chromosome Deletion; Chromo | 2006 |
Mood disorder in a patient with Smith-Magenis syndrome: a case report.
Topics: Adult; Chromosomes, Human, Pair 17; Craniofacial Abnormalities; Female; Gene Deletion; Humans; Intel | 2007 |
Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders.
Topics: Adolescent; Adult; Axilla; Body Temperature Regulation; Child; Circadian Rhythm; Epilepsy; Female; H | 1993 |
Melatonin secretion of the rat pineal gland in response to norepinephrine in different types of the anovulatory syndrome.
Topics: Animals; Anovulation; Female; Melatonin; Norepinephrine; Organ Culture Techniques; Perfusion; Pineal | 1997 |
Normal melatonin levels in patients with fibromyalgia syndrome.
Topics: Adult; Female; Fibromyalgia; Humans; Melatonin; Middle Aged; Pain Measurement; Quality of Life; Refe | 1998 |
Free-running of plasma melatonin rhythm prior to full manifestation of a non-24 hour sleep-wake syndrome.
Topics: Administration, Oral; Adult; Circadian Rhythm; Humans; Male; Melatonin; Polysomnography; Psychophysi | 1998 |
Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentrations in humans.
Topics: Adult; Circadian Rhythm; Electromagnetic Fields; Humans; Low Back Pain; Male; Melatonin; Middle Aged | 1998 |
[The jet lag syndrome].
Topics: Circadian Rhythm; Humans; Italy; Melatonin; Phototherapy; Sleep Wake Disorders; Sports; Syndrome; Tr | 1999 |
Poor recovery sleep after sleep deprivation in delayed sleep phase syndrome.
Topics: Adult; Circadian Rhythm; Homeostasis; Humans; Male; Melatonin; Reference Values; Sleep Deprivation; | 1999 |
Characterisation of headshaking syndrome--31 cases.
Topics: Animals; Antioxidants; Behavior, Animal; Cyproheptadine; Female; Horses; Male; Melatonin; Recurrence | 1998 |
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Topics: Adult; Anorexia; Circadian Rhythm; Feeding and Eating Disorders; Feeding Behavior; Female; Humans; H | 1999 |
Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Child; Child, Preschool; Chromosomes, Human, Pair 17; Ci | 2000 |
Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Child; Child, Preschool; Chromosomes, Human, Pair 17; Ci | 2000 |
Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Child; Child, Preschool; Chromosomes, Human, Pair 17; Ci | 2000 |
Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Child; Child, Preschool; Chromosomes, Human, Pair 17; Ci | 2000 |
Polysomnography in hypnic headache syndrome.
Topics: Aged; Female; Headache; Humans; Indomethacin; Male; Melatonin; Middle Aged; Polysomnography; Recurre | 2000 |
Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Adolescent; Case-Control Studies; Child; Child Behavior Disorders; Child, P | 2001 |
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Behavior; Child; Child, Preschool; Chromosomes, | 2001 |
The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Cataplexy; Circadian Rhythm; Combined Modality Therapy; F | 1992 |
Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.
Topics: Adult; Chronic Disease; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydr | 1986 |
Melatonin state in Mendenhall's syndrome.
Topics: Diabetes Mellitus, Type 1; Humans; Hypoglycemia; Infant, Newborn; Insulin Resistance; Male; Melatoni | 1988 |
Neuroendocrine rhythms in a patient with the Kleine-Levin syndrome.
Topics: Adolescent; Circadian Rhythm; Disorders of Excessive Somnolence; Feeding and Eating Disorders; Femal | 1985 |
Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome.
Topics: Adult; Circadian Rhythm; Depressive Disorder; Dexamethasone; Female; Grief; Humans; Hydrocortisone; | 1985 |